Colgate-Palmolive Q3 profit beats estimates

Colgate-Palmolive

31/10/2025 11:06

Overview

Colgate-Palmolive Q3 net sales rise 2%, beating analyst expectations

Adjusted EPS for Q3 beats analyst estimates

Company exits non-strategic private label pet sales, impacting organic sales growth

Outlook

Company expects full-year 2025 organic sales growth of 1% to 2%

Colgate-Palmolive sees full-year net sales up low single digits

Company expects full-year gross profit margin to align with 60.1%

2030 strategy and Strategic Growth and Productivity Program are positioned to drive growth

Result Drivers

CATEGORY SLOWDOWN - Despite slowing category growth in many markets, Colgate-Palmolive achieved net and organic sales growth

EXIT FROM PET SALES - Organic sales were negatively impacted by the exit from non-strategic private label pet sales

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Sales
Meet
$5.13 bln
$5.13 bln (12 Analysts)
Q3 Adjusted EPS
Beat
$0.91
$0.89 (15 Analysts)
Q3 EPS
$0.91


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", 9 "hold" and 2 "sell" or "strong sell"

The average consensus recommendation for the personal products peer group is "buy"

Wall Street's median 12-month price target for Colgate-Palmolive Co is $90.00, about 15% above its October 30 closing price of $76.51

The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 24 three months ago

Press Release: ID:nBw3xnrnca

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)